-
Finland building icebreakers for US amid Arctic tensions
-
Petro extradites drug lord hours before White House visit
-
Disney names theme parks chief Josh D'Amaro as next CEO
-
Disney names theme parks boss chief Josh D'Amaro as next CEO
-
Macron says work under way to resume contact with Putin
-
Prosecutors to request bans from office in Le Pen appeal trial
-
Tearful Gazans finally reunite after limited Rafah reopening
-
Iran president confirms talks with US after Trump's threats
-
Spanish skater allowed to use Minions music at Olympics
-
Fire 'under control' at bazaar in western Tehran
-
Howe trusts Tonali will not follow Isak lead out of Newcastle
-
Vonn to provide injury update as Milan-Cortina Olympics near
-
France summons Musk for 'voluntary interview', raids X offices
-
Stocks mostly climb as gold recovers
-
US judge to hear request for 'immediate takedown' of Epstein files
-
Russia resumes large-scale strikes on Ukraine in glacial temperatures
-
Fit-again France captain Dupont partners Jalibert against Ireland
-
French summons Musk for 'voluntary interview' as authorities raid X offices
-
IOC chief Coventry calls for focus on sport, not politics
-
McNeil's partner hits out at 'brutal' football industry after Palace move collapses
-
Proud moment as Prendergast brothers picked to start for Ireland
-
Germany has highest share of older workers in EU
-
Teen swims four hours to save family lost at sea off Australia
-
Ethiopia denies Trump claim mega-dam was financed by US
-
Norway crown princess's son pleads not guilty to rapes as trial opens
-
Russia resumes strikes on freezing Ukrainian capital ahead of talks
-
Malaysian court acquits French man on drug charges
-
Switch 2 sales boost Nintendo profits, but chip shortage looms
-
China to ban hidden car door handles, setting new safety standards
-
Switch 2 sales boost Nintendo results but chip shortage looms
-
From rations to G20's doorstep: Poland savours economic 'miracle'
-
Russia resumes strikes on freezing Ukrainian capital
-
'Way too far': Latino Trump voters shocked by Minneapolis crackdown
-
England and Brook seek redemption at T20 World Cup
-
Coach Gambhir under pressure as India aim for back-to-back T20 triumphs
-
'Helmets off': NFL stars open up as Super Bowl circus begins
-
Japan coach Jones says 'fair' World Cup schedule helps small teams
-
Equities and precious metals rebound after Asia-wide rout
-
Do not write Ireland off as a rugby force, says ex-prop Ross
-
Winter Olympics 2026: AFP guide to Alpine Skiing races
-
Winter Olympics to showcase Italian venues and global tensions
-
Buoyant England eager to end Franco-Irish grip on Six Nations
-
China to ban hidden car door handles in industry shift
-
Sengun leads Rockets past Pacers, Ball leads Hornets fightback
-
Waymo raises $16 bn to fuel global robotaxi expansion
-
Netflix to livestream BTS comeback concert in K-pop mega event
-
Rural India powers global AI models
-
US House to vote Tuesday to end shutdown
-
Equities, metals, oil rebound after Asia-wide rout
-
Bencic, Svitolina make history as mothers inside tennis top 10
Florence Healthcare Launches SiteLink on AWS Marketplace, Extending its Clinical Trial Operations Platform Capabilities to Cloud
ATLANTA, GEORGIA / ACCESS Newswire / October 28, 2025 / Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors and research sites worldwide, announced today that SiteLink, a key offering of Florence's Trial Operations Platform, is now available in AWS Marketplace.
SiteLink accelerates study startup and enables real-time document distribution, monitoring, and data exchange with study sites, addressing the critical digital divide in clinical trials. With only 30% of global research sites currently using digital workflows, SiteLink helps bridge this gap by automating sponsor-site operational workflows.
Bringing the Florence Trial Operations Platform Benefits to AWS
As a core component of Florence's Trial Operations Platform, SiteLink delivers the same proven results that have made Florence the #1 clinical trial management solution for six consecutive years.
The platform enables:
Faster Startup: Up to 70% faster study activation timelines through automated feasibility, site selection, and document exchange workflows.
Increased Efficiency: Significant operational cost reduction by automating critical sponsor-site workflows.
Reduced Risk: Improved eTMF QA pass rates from 65% to 98.7% with built-in compliance checks.
"AWS customers represent some of the most innovative companies in life sciences, and they deserve access to the most advanced clinical trial technology available," said Chad Garrett, Chief Revenue Officer at Florence Healthcare. "By making SiteLink available through AWS Marketplace, we're extending our Trial Operations Platform capabilities; enabling sponsors and CROs to digitize site operations and gain comprehensive portfolio visibility."
Powered by AI and Built for Scale
SiteLink leverages Florence's AI-powered workflows and risk-based intelligence to deliver early risk detection, automated compliance checks, and real-time operational insights. The solution maintains full alignment with FDA, EMA, HIPAA, GDPR, EU Annex 11, ICH E6 (R3), and GCP standards.
About Availability
SiteLink is now generally available in AWS Marketplace. For more information about Florence Healthcare, visit www.florencehc.com
About Florence Healthcare
Florence is a purpose-built platform that connects sponsors and sites to accelerate clinical trials, improve operational capacity, and reduce risk. Designed for scale, Florence streamlines workflows, enhances collaboration, and delivers real-time visibility across studies, empowering research teams to move faster, stay inspection-ready, and increase trial throughput with fewer resources.
CONTACT:
Seema Sheth-Voss
[email protected]
(888) 829-0896
SOURCE: Florence Healthcare
View the original press release on ACCESS Newswire
Y.Baker--AT